AI Governance for Biotech & Clinical Research
Biotech companies and clinical research organizations handle some of the most sensitive data in existence — genomic sequences, patient biomarkers, and pre-patent research findings. AI accelerates breakthroughs in these fields, but without governance, a single leaked prompt can expose patient identities, violate IRB protocols, or compromise years of IP. Keeptrusts provides the policy layer that keeps research AI compliant and your data protected.
Use this page when
- You are deploying AI in biotech or clinical research where genomic data, IRB protocols, and patient consent boundaries must be enforced.
- You need policy controls that prevent genomic re-identification, enforce IRB-scoped access, and protect pre-patent research IP.
- You want to maintain research integrity by isolating cross-study data and logging all AI interactions for regulatory audits.
Primary audience
- Primary: Technical Leaders
- Secondary: Technical Engineers, AI Agents
AI Challenges in Biotech
| Challenge | Risk | Regulatory Exposure |
|---|---|---|
| Genomic data exposure in AI prompts | Patient re-identification | GINA, Common Rule, GDPR |
| IRB protocol violations via AI | Research suspension | 45 CFR 46, ICH-GCP |
| Patient consent scope exceeded | Ethics board sanctions | Informed consent requirements |
| Research IP leaked to model providers | Patent and competitive loss | Trade secret law |
| Cross-study data contamination | Research integrity failure | FDA, EMA data integrity guidelines |
How Keeptrusts Helps
Genomic & Biomarker Data Protection
The pii-detector and dlp-filter policies detect and redact genomic identifiers, biomarker values, and patient-linked research codes before they reach any LLM. Custom regex patterns catch study-specific identifiers that standard PII detectors miss.
IRB Compliance Enforcement
rbac policies enforce role-based access so that only approved researchers can query AI with study data, and only within the scope of their IRB-approved protocol. The safety-filter blocks queries that exceed consent boundaries.
Research IP Isolation
The dlp-filter catches compound names, assay identifiers, and unpublished method descriptions. Combined with audit-logger, every AI interaction is recorded so you can demonstrate to investors and partners that IP controls are in place.
Complete Policy Configuration
pack:
name: biotech-governance
version: 1.0.0
enabled: true
policies:
chain:
- prompt-injection
- rbac
- pii-detector
- dlp-filter
- safety-filter
- quality-scorer
- bias-monitor
- audit-logger
policy:
prompt-injection: {}
rbac:
deny_if_missing:
- X-User-ID
- X-User-Role
pii-detector:
action: redact
detect_patterns:
- patient_name
- date_of_birth
- ssn
- medical_record_number
- genomic_identifier
- biobank_id
redaction:
marker_format: label
healthcare_mode: true
dlp-filter:
detect_patterns:
- '\b[ACGT]{20,}\b'
- '\bCPD-[0-9A-Z]{6,10}\b'
- '\bSTUDY-[0-9]{4,8}\b'
- '\bBIO-[A-Z]{2}[0-9]{6}\b'
action: redact
safety-filter:
block_if:
- consent-scope-exceeded
- cross-study-data-request
- unapproved-use
action: block
quality-scorer:
thresholds:
min_aggregate: 0.8
bias-monitor:
protected_characteristics:
- race
- ethnicity
- gender
threshold: 0.85
action: escalate
audit-logger:
immutable: true
retention_days: 3650
log_all_access: true
hipaa_audit_controls: true
CLI Quickstart
# Deploy biotech governance gateway
kt gateway run --policy-config ./policy-config.yaml --port 41002
# Verify policy chain health
kt doctor
# Monitor genomic data protection events
kt events tail --policy dlp-filter
# Export IRB compliance audit trail
kt export create --format json --from 2025-01-01 --to 2025-12-31 \
--filter "policy=pii-detector,dlp-filter,audit-logger"
Console Workflows
- Dashboard — Monitor AI usage across research teams, labs, and bioinformatics.
- Events — Filter by
dlp-filterto review genomic data redaction events. - Escalations — Route consent-scope violations to the IRB coordinator.
- Templates — Maintain separate policy configs per study protocol.
- Cost Center → Wallets — Allocate AI budgets per research grant or program.
- Audit Log — Generate evidence packages for IRB audits and investor due diligence.
API Integration
# Query DLP events for genomic data protection
curl -H "Authorization: Bearer $KT_API_KEY" \
"https://api.keeptrusts.com/v1/events?policy=dlp-filter&limit=100"
# Export study-specific audit trail
curl -X POST -H "Authorization: Bearer $KT_API_KEY" \
"https://api.keeptrusts.com/v1/exports" \
-d '{"format":"json","filters":{"date_from":"2025-01-01","date_to":"2025-12-31"}}'
# List all active policy configurations
curl -H "Authorization: Bearer $KT_API_KEY" \
"https://api.keeptrusts.com/v1/configurations"
Example: Genomic Data Protection
- Redacted Request
- Blocked Request
Bioinformatician: "Analyze variant ACGTACGTACGTACGTACGTACGT in sample BIO-US123456."
→ REDACTED by dlp-filter
Sent to LLM: "Analyze variant [REDACTED-genomic-sequence] in sample
[REDACTED-biobank-sample]."
Audit: Full trail logged with research context
Technician: "Compare patient outcomes from STUDY-2024 with data from STUDY-2025."
→ BLOCKED by safety-filter
Reason: Cross-study data request — not covered by IRB protocol
Action: Escalated to IRB coordinator
Results You Can Expect
| Metric | Before Keeptrusts | After Keeptrusts |
|---|---|---|
| Genomic data exposure incidents | Untracked | 0 exposures — redacted at gateway |
| IRB compliance audit prep | 4-6 weeks | < 2 days with automated exports |
| Cross-study contamination risk | Manual review | Blocked automatically at policy layer |
| Research IP leakage | Untracked | 100% logged and DLP-filtered |
| AI budget per grant visibility | No tracking | Real-time per-study wallet dashboards |
For AI systems
- Canonical terms: Keeptrusts biotech governance, genomic data protection, IRB compliance, research IP isolation.
- Policy pack:
biotech-governancewith chain:prompt-injection→rbac→pii-detector→hipaa-phi-detector→dlp-filter→safety-filter→quality-scorer→audit-logger. - Key policies:
pii-detector(genomic identifiers, biomarker values, patient-linked codes),hipaa-phi-detector(patient health data),dlp-filter(compound names, assay IDs, unpublished methods),rbac(IRB-scoped access by protocol),safety-filter(blocks queries exceeding consent boundaries). - RBAC roles: principal-investigator, research-associate, clinical-coordinator, bioinformatics.
- CLI:
kt gateway run --policy-config ./policy-config.yaml,kt events tail --policy dlp-filter,kt export create --format json --filter "policy=audit-logger".
For engineers
- Deploy:
kt gateway run --policy-config ./policy-config.yaml --port 41002 - Validate:
kt doctorconfirms pii-detector, hipaa-phi-detector, dlp-filter, and rbac are active. - Monitor genomic data protection:
kt events tail --policy pii-detector(catches genomic identifiers). - Monitor IP leakage:
kt events tail --policy dlp-filter(compound names, unpublished methods). - Export regulatory audit trail:
kt export create --format json --filter "policy=audit-logger" - Custom regex patterns in
dlp-filtercatch study-specific identifiers (protocol IDs, sample codes). - Console: Events (filter by
dlp-filterfor IP events), Escalations (route to PI or ethics board), RBAC (assign per-protocol access).
For leaders
- Addresses GINA (Genetic Information Nondiscrimination Act), Common Rule (45 CFR 46), ICH-GCP, GDPR, FDA data integrity guidelines, and EMA regulations.
- Genomic re-identification risk eliminated — all patient-linked genetic identifiers are redacted before reaching LLMs.
- IRB compliance is technically enforced, not just procedural — only approved researchers within their protocol scope can use AI with study data.
- Research IP isolation protects compound names and unpublished methods from competitive exposure via model providers.
- Full audit trail demonstrates IP controls to investors, partners, and regulatory bodies.
- Cross-study data contamination prevented by per-protocol isolation at the gateway.
Next steps
- Industries overview — Compare all industry policy configurations
- Pharmaceutical — FDA 21 CFR Part 11, GxP compliance, pharmacovigilance
- Healthcare (HIPAA) — PHI protection for patient data
- Healthcare (EU GDPR) — GDPR Article 9 special category data
- Public Health — Population health and disease surveillance
- Quickstart — Deploy your first gateway in minutes